NCT07071610View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 18, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

LNK01004 ointment 0.3%

LNK01004 ointment 0.3% BID

DRUG

LNK01004 ointment 1.0%

LNK01004 ointment 1.0% BID

DRUG

Vehicle

vehicle BID

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Lynk Pharmaceuticals Co., Ltd

INDUSTRY